Malin Corporation | MLC - Operating Profit


Malin Corporation reported EUR-1.1M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ALKERMES USD -10.95M 100.03M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Eurofins Scientific SE EUR 391.3M 139.6M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lonza CHF 673M 243M Jun/2025
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025